| High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa FY Tso, SJ Lidenge, PB Peña, AA Clegg, JR Ngowi, J Mwaiselage, ... International Journal of Infectious Diseases 102, 577-583, 2021 | 220 | 2021 |
| Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma FY Tso, SJ Lidenge, LK Poppe, PB Peña, SR Privatt, SJ Bennett, ... PLoS One 16 (3), e0247640, 2021 | 64 | 2021 |
| Evolutionary and structural analyses of alpha-papillomavirus capsid proteins yields novel insights into L2 structure and interaction with L1 J Lowe, D Panda, S Rose, T Jensen, WA Hughes, FY Tso, PC Angeletti Virology journal 5 (1), 150, 2008 | 51 | 2008 |
| RNA-Seq of Kaposi’s sarcoma reveals alterations in glucose and lipid metabolism FY Tso, AV Kossenkov, SJ Lidenge, O Ngalamika, JR Ngowi, ... PLoS pathogens 14 (1), e1006844, 2018 | 50 | 2018 |
| Brain is a potential sanctuary for subtype C HIV-1 irrespective of ART treatment outcome FY Tso, G Kang, EH Kwon, P Julius, Q Li, JT West, C Wood PloS one 13 (7), e0201325, 2018 | 41 | 2018 |
| Reduction of Kaposi's sarcoma-associated herpesvirus latency using CRISPR-Cas9 to edit the latency-associated nuclear antigen gene FY Tso, JT West, C Wood Journal of virology, JVI. 02183-18, 2019 | 40 | 2019 |
| Kaposi’s sarcoma-associated herpesvirus infection of neurons in HIV positive patients FY Tso, A Sawyer, EH Kwon, V Mudenda, D Langford, Y Zhou, J West, ... Journal of Infectious Diseases, jiw545, 2016 | 30 | 2016 |
| Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses Z Kraft, K Strouss, WF Sutton, B Cleveland, FY Tso, P Polacino, ... Journal of virology 82 (12), 5912-5921, 2008 | 25 | 2008 |
| Similar immunological profiles between african endemic and human immunodeficiency virus type 1–associated epidemic Kaposi Sarcoma (KS) patients reveal the primary role of KS … SJ Lidenge, FY Tso, O Ngalamika, JR Ngowi, Y Mortazavi, EH Kwon, ... The Journal of infectious diseases 219 (8), 1318-1328, 2019 | 23 | 2019 |
| Early initiation of antiretroviral therapy can functionally control productive HIV-1 infection in humanized-BLT mice Q Li, G Kang, W Lu, Y Li, W Fan, Z Yuan, CJ Destache, C Wood JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (5), 519-527, 2015 | 22 | 2015 |
| Comparative transcriptome analysis of endemic and epidemic Kaposi’s sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis SJ Lidenge, AV Kossenkov, FY Tso, J Wickramasinghe, SR Privatt, ... PLoS pathogens 16 (7), e1008681, 2020 | 16 | 2020 |
| Lack of CD8+ T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors SJ Lidenge, FY Tso, O Ngalamika, J Kolape, JR Ngowi, J Mwaiselage, ... Oncotarget 11 (17), 1556, 2020 | 16 | 2020 |
| Prevalence of Kaposi's sarcoma-associated herpesvirus and transfusion-transmissible infections in Tanzanian blood donors SJ Lidenge, T Tran, FY Tso, JR Ngowi, DM Shea, J Mwaiselage, C Wood, ... International Journal of Infectious Diseases 95, 204-209, 2020 | 15 | 2020 |
| The Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals Y Mortazavi, SJ Lidenge, T Tran, JT West, C Wood, FY Tso Viruses 12 (3), 256, 2020 | 13 | 2020 |
| Outcome markers of ART-treated HIV+ patients with early stage Kaposi’s sarcoma O Ngalamika, FY Tso, S Lidenge, S Munsaka, D Shea, C Wood, J West PLoS One 15 (7), e0235865, 2020 | 9 | 2020 |
| A comparative study of HIV-1 clade C env evolution in a Zambian infant with an infected rhesus macaque during disease progression FG Hoffmann, DC Tully, P Lemey, RA Rasmussen, H Zhang, ... Aids 23 (14), 1817-1828, 2009 | 9 | 2009 |
| SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study O Ngalamika, SJ Lidenge, MC Mukasine, M Kawimbe, P Kamanzi, ... International Journal of Infectious Diseases 127, 106-115, 2023 | 8 | 2023 |
| Viral and immunological analytes are poor predictors of the clinical treatment response in Kaposi’s sarcoma patients SJ Lidenge, FY Tso, Y Mortazavi, JR Ngowi, DM Shea, J Mwaiselage, ... Cancers 12 (6), 1594, 2020 | 7 | 2020 |
| Dynamics of envelope evolution in clade C SHIV-infected pig-tailed macaques during disease progression analyzed by ultra-deep pyrosequencing FY Tso, DC Tully, S Gonzalez, C Quince, O Ho, P Polacino, RM Ruprecht, ... Plos one 7 (3), e32827, 2012 | 6 | 2012 |
| Elevated iNOS and 3′-nitrotyrosine in Kaposi's sarcoma tumors and mouse model O Vladimirova, S Soldan, C Su, A Kossenkov, O Ngalamika, FY Tso, ... Tumour virus research 15, 200259, 2023 | 4 | 2023 |
